Abstract
The metabolic, endocrine and drug-induced myopathies are discussed in this chapter as a related group of disorders because, in a general sense, they share a common pathogenetic mechanism. The metabolic myopathies result from a biochemical defect in muscle metabolism itself, the endocrine myopathies from an abnormal hormonal environment, probably affecting muscle metabolism, and the drug-induced myopathies from a direct toxic effect of the drug on muscle metabolism. In some drug-induced myopathies, e.g. malignant hyperpyrexia myopathy, the drug effect is manifest only in susceptible individuals.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Afifi, A.K., Bergman, R.A. and Harvey, J.C. (1968) Steroid myopathy: clinical, histological and cytological observations. Johns Hopkins Med. J., 123, 158–174.
Askari, A., Vignos, P. J. Jr. and Moskowitz, R.W. (1976) Steroid myopathy in connective tissue diseases. Am. J. Med., 61, 485–492.
Bank, W.J., Di Mauro, S., Bonilla, E. et al. (1975) A disorder of lipid metabolism and myoglobinuria. N. Engl. J. Med., 292, 443–449.
Berenberg, R.A., Pellock, J.M., Di Mauro, S. et al. (1977) Lumping or splitting? ‘Opthalmoplegia plus’ or Kearns-Sayre syndrome? Ann. Neurol., 1, 37–54.
Berkovic, S.F., Carpenter, S., Evans, A. et al. (1989) Myoclonus epilepsy and ragged-red fibres (MERRF), Brain, 112, 1231–1260.
Bonilla, E. and Schotland, D.L. (1970) Histochemical diagnosis of muscle phosphofructokinase deficiency. Arch. Neurol., 22, 8–12.
Brunberg, J.A., McCormick, W.F. and Schochet, S.S. (1971) Type III glycogenosis. An adult with diffuse weakness and muscle wasting. Arch. Neurol., 25, 171–178.
Busch, H.F.M., Koster, J.F. and van Weerden, T.W. (1979) Infantile and adult-onset acid maltase deficiency occurring in the same family. Neurology, 29, 415–416.
Cornelio, F. and Di Donato, S. (1985) Myopathies due to enzyme deficiencies. J.Neurol., 232, 329–340.
Denborough, M.A., Dennett, X. and Anderson, P.M. (1973) Central core disease and malignant hyperpyrexia. Br. Med. J., 1, 272–273.
Di Mauro, S. and Hartlage, P.L. (1978) Fatal infantile form of muscle Phosphorylase deficiency. Neurology, 28, 1124–1129.
Di Mauro, S., Arnold, S., Miranda, A. and Rowland, L.P. (1978) McArdle’s disease: the mystery of reappearing Phosphorylase activity in muscle culture — a fetal isoenzyme. Ann. Neurol., 3, 60–66.
Di Mauro, S., Bonilla, E., Zeviani, M. et al. (1989) Mitochondrial myopathies. J. Inherit. Metab. Dis., 10, Suppl. 1,113–128.
Di Mauro, S., Hartwig, G.B., Hayes, A. et al. (1979) Debranching enzyme deficiency: neuromuscular disorders in 5 adults. Ann. Neurol., 5, 422–436.
Dubowitz, V. and Brooke, M.H. (1973) Muscle Biopsy — A Modern Approach, W.B. Saunders, London.
Ellis, F.R. and Halsall, P. J. (1980) Malignant hyperpyrexia. Br. J. Hosp. Med., 24, 318–327.
Engel, A.G. (1966) Electron microscopic observations in thyrotoxic and corticosteroid-induced myopathies. Mayo Clin. Proc, 41, 785–796.
Engel, A.G. (1970a) Acid maltase deficiency in adults. Brain, 93, 599–606.
Engel, A.G. (1970b) Evolution and content of vacuoles in primary hypokalemic periodic paralysis. Mayo Clin. Proc, 45, 774–814.
Engel, A.G. and Angelini, C. (1973) Carnitine deficiency of human muscle with associated lipid storage myopathy: a new syndrome. Science, 179, 899–902.
Engel, W.K. (1971) ‘Ragged-red fibres’ in ophthalmoplegia syndromes and their differential diagnosis. In Muscle Diseases (ed. B. A. Kakulas), ICS 237, Excerpta Medica, Amsterdam, p. 28.
Ferguson, I.T., Mahon, M. and Cumming, W.J.K. (1983) An adult case of Andersen’s disease: Type IV glycogenosis. J. Neurol. Sci., 60, 337–351.
Godet-Guillain, J. and Fardeau, M. (1970) Hypothyroid myopathy: histological and ultrasfructural study of an atrophic form. In Muscle Diseases (eds J.N. Walton, N. Canal and S. Scarlato), ICS 199, Excerpta Medica, Amsterdam, pp. 512–515.
Guze, B.H. and Baxter, L.R. (1986) Neuroleptic malignant syndrome. N. Engl. J. Med., 313, 163–166.
Hogan, G.R., Gutamann, L., Schmidt, R. and Gilbert, E. (1969) Pompe’s disease. Neurology, 19, 894–900.
Holt, I.J., Harding, A.E. and Morgan-Hughes, J.A. (1988) Deletions of mitochondrial DNA in patients with mitochondrial myopathies. Nature, 331, 717–719.
Karpati, G., Carpenter, S., Engel, A.G. et al. (1975) The syndrome of systemic carnitine deficiency . Neurology, 25, 16–24.
Karpati, G., Carpenter, S., Eisen, A. et al. (1977) The adult form of acid maltase (a1 : 4 glucosidase) deficiency. Ann. Neurol., 1, 276–280.
Lombes, A., Bonilla, E. and Di Mauro, S. (1989) Mitochondrial encephalo-myopathies. Rev. Neurol., 145, 671–689.
McArdle, B. (1951) Myopathy due to a defect in muscle glycogen breakdown. Clin. Sci., 10, 13–33.
McKeran, R.O., Slavin, G., Ward, P. et al. (1980) Hypothyroid myopathy: a clinical and pathological study. J. Pathol., 132, 35–54.
McMaster, K.R., Powers, J.M., Hennigar, G.R. et al (1979) Nervous system involvement in Type IV glycogenosis. Arch. Pathol. Lab. Med., 103, 105–111.
Markowitz, H. and Wobig, G.H. (1977) Quantitative method for estimating myoglobin in urine. Clin. Chem., 23, 1689–1693.
Martin, D.T. and Swash, M. (1987) Muscle pathology in the neuroleptic malignant syndrome. J. Neurol., 235, 120–121.
Mastaglia, F.L. and Argov, Z. (1981) Drug-induced neuromuscular disorders in man. In Disorders of Voluntary Muscle, 4th edn (ed. J.N. Walton), Churchill Livingstone, Edinburgh, pp. 873–906.
Mastaglia, F.L., Barwick, D.D. and Hall, R. (1970) Myopathy in acromegaly. Lancet, 2, 907–909.
Moraes, C.T., Di Mauro, S., Zeviani, M. et al. (1989) Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N. Engl. J.Med., 320, 1293–1299.
Morgan, K.G. and Bryant, S.H. (1977) The mechanism of action of dantrolene sodium. J. Pharmacol. Exp. Ther., 201, 138–141.
Morgan-Hughes, J.A. (1989) The metabolic myopathies. Curr. Opin. Neurol. Neurosurg., 2, 689–694.
Nagulesparen, M., Trickey, R., Davies, M. J. and Jenkins, J.S. (1976) Muscle changes in acromegaly. Br. Med.J., 2, 914–915.
Olson, W., Engel, W.K., Walsh, G.O. and Einaugler, R. (1972) Oculo-cranio-somatic neuromuscular disease with ‘ragged-red fibres’. Histochemical and ultrastructural changes in limb muscles of a group of patients with idiopathic progressive external ophthalmoplegia. Arch. Neurol., 26, 193–211.
Petty, R.K.H., Harding, A.E. and Morgan-Hughes, J.A. (1986) The clinical features of mitochondrial myopathy. Brain, 109, 915–938.
Pleasure, D.E., Walsh, G.O. and Engel, W.K. (1970) Atrophy of skeletal muscles in patients with Cushing’s syndrome. Arch. Neurol., 22, 118–125.
Rebouche, C. J. and Engel, A.G. (1983) Carnitine metabolism and deficiency syndromes. Mayo Clin. Proc, 58, 533–540.
Ross, B.D., Radda, G.K., Godian, D.G. et al. (1981) Examination of a case of suspected McArdle’s syndrome by 31P nuclear magnetic resonance. N. Engl. J. Med., 304, 1338–1342.
Rubenstein, A.E. and Wainapel, S.F. (1977) Acute hypokalemic myopathy in alcoholism. Arch. Neurol., 34, 553–555.
Schiller, H.H. and Mair, W.G.P. (1974) Ultrastructural changes of muscle in malignant hyperthermia. J. Neurol. Sci., 21, 93–100.
Schott, G.D. and Wills, M.R. (1975) Myopathy in hypophosphataemic osteomalacia presenting in adult life. J. Neurol. Neurosurg. Psychiatry, 38, 297–304.
Servidei, S., Shanske, S., Zeviani, M. et al. (1988) McArdle’s disease: biochemical and molecular genetic studies. Ann. Neurol., 24, 774–781.
Shirabe, T., Tawara, S., Terao, A. and Araki, S. (1975) Myxoedematous polyneuropathy. J. Neurol. Neurosurg. Psychiatry, 38, 241–247.
Swash, M. and Schwartz, M.S. (1983) Iatrogenic neuromuscular disorders: a review. Proc. R. Soc. Med., 76, 149–151.
Swash, M., Schwartz, M.S. and Apps, M.C.P. (1985) Adult-onset acid maltase deficiency. J. Neurol. Sci., 68, 61–74.
Tarui, S., Kono, N., Nasu, T. and Nishikawa, M. (1969) Enzymatic basis for the co-existence of myopathy and hemolytic disease in inherited muscle phosphofructokinase deficiency. Biochem. Biophys. Res. Comm., 34, 77–83.
Tassin, S. and Brucher, J.M. (1982) The mitochondrial disorders: pathogenesis and aetiological classification. Neuropathol. Appl. Neurobiol., 8, 251–263.
Tassin, S., Walter, G.F., Brucher, J.M. and Rousseau, J. J. (1980) Histochemical and ultrastructural analysis of the mitochondrial changes in a familial mitochondrial myopathy. Neuropathol. Appl. NeurobioL, 6, 227–247.
Tobin, W.E., Hijing, F., Porro, R.S. and Salzman, R.T. (1973) Muscle phosphofructokinase deficiency. Arch. Neurol., 28, 128–130.
Van der Walt, J.D., Swash, M., Leake, J. and Cox, E.L. (1987) The pattern of involvement of adult-onset acid maltase deficiency at autopsy. Muscle Nerve, 10, 272–281.
Weiler, R.O. and McArdle, B. (1971) Calcification within muscle fibres in the periodic paralyses. Brain, 94, 263–272.
Willner, J., Di Mauro, S., Eastwood, A. et al. (1979) Muscle carnitine deficiency: genetic heterogeneity. J. Neurol. Sci., 41, 235–246.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1991 M. Swash and M.S. Schwartz
About this chapter
Cite this chapter
Swash, M., Schwartz, M.S. (1991). Metabolic, endocrine and drug-induced myopathies. In: Biopsy Pathology of Muscle. Biopsy Pathology Series. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3400-0_8
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3400-0_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-34880-8
Online ISBN: 978-1-4899-3400-0
eBook Packages: Springer Book Archive